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LATE RUPTURE OF EXPANDED
POLYTETRAFLUORO-
ETHYLENE NEOCHORDAE
USED FOR MITRALVALVE
REPAIR
To the Editor:
In the February issue of the Journal,
Farivar and colleagues1 described
a case of late rupture of expanded
polytetrafluoroethylene (ePTFE) neo-
chordae after mitral valve repair. In the
‘‘Discussion,’’ they state that there
was only 1 previous case reported in
the literature of ruptured neochordae,
presented by Buttany and colleagues,2
suggesting their case as the second re-
ported. This is not correct. In 2007, the
Journal of Heart Valve Disease pub-
lished our report of 2 cases of acute mi-
tral regurgitation caused by ruptured
ePTFE neochordae.3 Our patients pre-
sented with symptoms of acute heart
failure caused by sudden rupture of the
chordae, which was different from the
rare clinical manifestations, hemolysis,
and hematuria experienced by the pa-
tient reportedbyFarivar and colleagues.
We first used ePTFE routinely to
correct ruptured or elongated chordae
tendineae during the late 1980s and
have since implanted it in more than
500 patients without a single known
case of ePTFE failure necessitating re-
operation, until these 2 late events oc-
curred. After a thorough literature
search regarding the possible mecha-
nisms behind this unusual occurrence,
we analyzed our histopathologic find-
ings. We found that there was likely
pannus formation and collagen infil-
tration through the porous structure
that could account for progressive dis-
ruption before calcification ensued,
which could be postulated as a form
of repair/scarring.
In addition to the degenerative
causes that could be responsible for
the late rupture, we believe that the
use of forceps and other metal instru-
ments in the manipulation of the
ePTFE could interrupt its electronega-
tive charge and weaken the material.
We currently avoid any kind of metal-
lic manipulation.
Gonc¸alo Coutinho, MD
Lina Carvalho, MD, PhD
Manuel J. Antunes, MD, PhD, DSc
Center of Cardiothoracic Surgery
University Hospital
Coimbra, Portugal
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Letters to the Editor
The JournBIVENTRICULAR PACING
AFTER CARDIAC SURGERY
To the Editor:
We read with interest the article by
Evonich and colleagues1 in the Octo-
ber issue of the Journal. They per-
formed a randomized study of pacing
modes (‘‘normal care,’’ synchronous
atrial-right ventricular pacing, and
synchronous atrial–biventricular pac-
ing) in 40 patients with impaired left
ventricular function after cardiac sur-
gery. They included both a crossover
study of acute hemodynamic variablesal of Thoracic and Cardiovascular Surgearly after operation (in 29 patients)
and an assessment of clinical end
points, such as intensive therapy unit
and hospital stay andmortality. In con-
trast with experience in chronic heart
failure, they showed no advantage to
biventricular pacing in any area, al-
though the trial was underpowered
for the clinical end points.
They suggest this was the first ran-
domized study in surgical patients but
did not cite our 2005 publication.2
We performed a similar randomized
crossover study, with hemodynamic
assessment of different pacing modes
in a similar number of patients (25)
early after surgery. We demonstrated
a clear advantage to atrial–left ventric-
ular pacing and regard this modality as
an important addition to the postopera-
tive care of the compromised patient.
Closer analysis of the results in the
article by Evonich and colleagues1
suggests that there is a serious error
or that they too found an advantage
but did not recognize it. In the second
paragraph of the section titled ‘‘Hemo-
dynamic Testing,’’ they state a statisti-
cally significant difference in stroke
volume, cardiac output, and left ven-
tricular stroke work index between
AAI and atrial-right ventricular pacing.
But, in Table 2, the values they refer to
in the text are in the column under
atrial–biventricular pacing pacing. If
Table 2 is to be believed (and there is
inconsistency in nomenclature, does
AAI equate to ‘‘usual care’’?), these
investigators did see an advantage to
biventricular pacing.
We believe biventricular pacing is
of advantage to the postsurgical pa-
tient. Even if we are mistaken in our
interpretation of this article, surgeons
are left with 2 series of patients with
contrasting results, perhaps because
both have small numbers. This calls
for a larger definitive study.
Michael Flynn, FRCS
John H. Dark, FRCS
Janet M. McComb, FRCP, MD
University of Newcastle upon Tyne
United Kingdomery c Volume 138, Number 1 259
mate by up to 5 mm (3 mm in this
case report) the size of the aortic annu-
lus. In the present case, the chosen size
of the implanted valve was 23 mm.
The latter was supposed to be over-
sized based on the TTEmeasurements.
The surgically implanted valve was
also 23 mm based on the surgical mea-
surements. Despite ‘‘oversizing’’ in
this reported percutaneous valve im-
plantation, severe paravalvular leak
Hoˆpital Europe´en Georges Pompidou
Paris, France
cAssistance Publique-Hoˆpitaux de
Paris, AP-HP
Service de Cardiologie
Hoˆpital Europe´en Georges Pompidou
Paris, France
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VALVE IMPLANTATION: WHAT
DOES OVERSIZING MEAN?
To the Editor:
We read with interest the recent
article by Litzler and colleagues1 in
the Journal of Thoracic and Cardio-
vascular Surgery.The authors reported
their first case of emergency surgical
aortic valve replacement for severe
acute aortic regurgitation after retro-
grade transfemoral Cribier-Edwards
valve implantation.
We would like to comment on this
instructive case report and ask for
some clarifications:
When valved stent implantation is
planned in a patient, accurate pre-
procedural determination of the aortic
annulus size is of crucial importance.
A prosthesis–aortic annulus mismatch
may be responsible for valve migra-
tion or severe paravalvular leak if the
chosen prosthesis is too small and for
coronary obstruction or leaflet distor-
tion if it is too large.2
The incidence of paravalvular leak
has been shown to be dramatically
high in previous studies.3,4 To reduce
the incidence and severity of paravalvu-
lar leak, the oversizing technique (ie, the
choice of a prosthesis size at least 2 mm
more than that of the aortic annulus di-
ameter as determined by transthoracic
echocardiography [TTE]) has been pro-
posed and proved to be effective.4
Nevertheless, several previous stud-
ies have shown that measurement of
the aortic annulus diameter by TTE is
inaccurate when compared with surgi-
cal sizing.5 TTE tends to underesti-
occurred, which means, in a sense,
that this strategy has not solved this
major problem at the present time.
We would like to ask the authors
a few questions:
 What does ‘‘oversizing’’ mean for
them in the choice of the implant-
able valve ? Is oversizing based on
the TTE measurements of the aortic
annulus diameter or is it based on
the ‘‘true’’ aortic annulus diameter
if the latter could be measured?
 Do they still rely on TTE for deter-
mination of the aortic annulus diam-
eter or have they changed their
imaging technique?
 Have they changed the magnitude
of oversizing, based on this reported
experience?
 If so, how effective is their new ap-
proach regarding the occurrence of
paravalvular leak?
Optimal sizing of valved stents
remains a critical issue with many im-
plications on the post-procedural
course. The readers of the Journal
would greatly appreciate the answers
to these ‘‘practical’’ questions from
one of the most experienced teams in
interventional aortic valve therapy.
Rachid Zegdi, MD, PhDa,b
Paul Achouh, MD, PhDb
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PROGNOSTIC SIGNIFICANCE
OF VISCERAL PLEURAL
INVASION AND TUMOR SIZE IN
NON–SMALL CELL LUNG
CANCER
To the Editor:
We read with great interest the article
byShimizu and colleagues1 published in
the July 2005 issue of the Journal. They
found that visceral pleural invasion
(VPI) is a significant poor prognostic
factor of non–small cell lung cancer
(NSCLC), regardless of N status. Stage
I NSCLC has been subdivided into IA
(T1N0M0) and IB (T2N0M0) based on
tumor size (3 cm as a cutoff value) and
non–size-based T2 descriptors (includ-
ingVPI, hilar atelectasis, andobstructive
pneumonitis).2 Although a poor prog-
nostic effect of VPI has generally been
reported, its prognostic value for
survival has remained controversial.3,4
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